IGM Biosciences, Inc.
IGM Biosciences, Inc. (IGMS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
igms · pe ratio · data through Dec 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for IGM Biosciences, Inc. (IGMS) measures how much investors pay for each dollar of the company's trailing earnings. IGMS's current PE ratio of 9.70x is calculated by dividing its stock price of $1.27 by its TTM earnings per share of $0.13.
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31
PE Ratio History
2017 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
IGM Biosciences, Inc.You IGMS | $77M | 9.70x | — | $0.13 |
 Achilles Therapeutics plc ACHL | $61M | N/A | — | -$1.74 |
 Berkeley Lights, Inc. BLI | $87M | N/A | — | -$1.42 |
 Heat Biologics, Inc. HTBX | $61M | N/A | — | -$1.41 |
 Insight Molecular Diagnostics Inc. IMDX | $154M | N/A | — | -$1.65 |
 Jade Biosciences, Inc. JBIO | $489M | N/A | — | -$4.06 |
 Landos Biopharma, Inc. LABP | $72M | N/A | — | -$3.50 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-12-31Latest FY2024 | — | $-3.24 | — | |
2023-12-31 FY2023 | — | $-4.71 | — | |
2022-12-31 FY2022 | — | $-5.16 | — | |
2021-12-31 FY2021 | — | $-4.80 | — | |
2020-12-31 FY2020 | — | $-2.61 | — | |
2019-12-31 FY2019 | — | $-4.73 | — | |
2018-12-31 FY2018 | — | $-51.84 | — | |
2017-12-31 FY2017 | — | $-25.24 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for IGM Biosciences, Inc. (IGMS) measures how much investors pay for each dollar of the company's trailing earnings. IGMS's current PE ratio of 9.70x is calculated by dividing its stock price of $1.27 by its TTM earnings per share of $0.13.
Frequently asked questions
IGMS pe ratio · 6 questionsIGMS's current PE ratio is 9.70x as of 2026-06-09, based on a stock price of $1.27 and TTM EPS of $0.13. Data sourced from Financial Modeling Prep via IGMS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · IGM Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09